192 related articles for article (PubMed ID: 10834867)
21. Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals.
Al Jabri AA; Al Buloshi MS
Saudi Med J; 2004 Mar; 25(3):313-7. PubMed ID: 15048168
[TBL] [Abstract][Full Text] [Related]
22. Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
Rostaing L; Modesto A; Cisterne JM; Izopet J; Oksman F; Duffaut M; Abbal M; Durand D
Am J Nephrol; 1998; 18(1):50-6. PubMed ID: 9481439
[TBL] [Abstract][Full Text] [Related]
23. Anti-cardiolipin, anti-cardiolipin plus bovine, or human beta(2)glycoprotein-I and anti-human beta(2)glycoprotein-I antibodies in a healthy infant population.
Cabiedes J; Trejo-Hernández J; Loredo-Abdalá A; Castilla-Serna L; López-Mendoza AT; Cordero-Esperón HA; Huerta MT; Cabral AR; Alarcón-Segovia D
Arch Med Res; 2002; 33(2):175-9. PubMed ID: 11886718
[TBL] [Abstract][Full Text] [Related]
24. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
[TBL] [Abstract][Full Text] [Related]
25. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
[TBL] [Abstract][Full Text] [Related]
26. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
27. A study of autoimmune markers in hepatitis C infection.
Agarwal N; Handa R; Acharya SK; Wali JP; Dinda AK; Aggarwal P
Indian J Med Res; 2001 May; 113():170-4. PubMed ID: 11968950
[TBL] [Abstract][Full Text] [Related]
28. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
29. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura.
Kawakami T; Watabe H; Mizoguchi M; Soma Y
Br J Dermatol; 2006 Nov; 155(5):983-7. PubMed ID: 17034529
[TBL] [Abstract][Full Text] [Related]
30. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
Ali HY; Abdullah ZA
J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
32. Disease distribution of beta 2-glycoprotein I-dependent anticardiolipin antibodies in rheumatic diseases.
Kaburaki J; Kuwana M; Yamamoto M; Kawai S; Matsuura E; Ikeda Y
Lupus; 1995 Feb; 4 Suppl 1():S27-31. PubMed ID: 7757107
[TBL] [Abstract][Full Text] [Related]
33. IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.
Locht H; Wiik A
Clin Rheumatol; 2006 Mar; 25(2):246-50. PubMed ID: 16177835
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity.
Toubi E; Gordon S; Kessel A; Rosner I; Rozenbaum M; Shoenfeld Y; Zuckerman E
J Autoimmun; 2006 Sep; 27(2):134-9. PubMed ID: 17029886
[TBL] [Abstract][Full Text] [Related]
35. Anticardiolipin and antinuclear antibodies in cancer patients--a case control study.
Armas JB; Dantas J; Mendonça D; Farto R; Ribeiro M; Herrero-Beaumont G; Gouveia J; McHugh NJ
Clin Exp Rheumatol; 2000; 18(2):227-32. PubMed ID: 10812496
[TBL] [Abstract][Full Text] [Related]
36. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
[TBL] [Abstract][Full Text] [Related]
38. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
[TBL] [Abstract][Full Text] [Related]
39. Anticardiolipin antibodies in patients with liver disease.
Mangia A; Margaglione M; Cascavilla I; Gentile R; Cappucci G; Facciorusso D; Grandone E; Di Minno G; Rizzetto M; Andriulli A
Am J Gastroenterol; 1999 Oct; 94(10):2983-7. PubMed ID: 10520856
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and significance of anticardiolipin, anti-beta2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C.
Leroy V; Arvieux J; Jacob MC; Maynard-Muet M; Baud M; Zarski JP
Br J Haematol; 1998 Jun; 101(3):468-74. PubMed ID: 9633888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
